FDA Approved: DEFERASIROX — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Deferasirox from Actavis Pharma, Inc. This action updates the regulatory status of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Iron Overload
• Myelodysplastic Syndrome
• Sickle Cell Disease

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

SUPPL AP for DEFERASIROX (DEFERASIROX)